Find Perfluorohexyloctane manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 133331-77-8, 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorotetradecane, Perfluorohexyloctane, 7vyx4elwqm, Perfluorohexyloctane [who-dd], 1,1,1,2,2,3,3,4,4,5,5,6,6,-tridecafluorotetradecane
Molecular Formula
C14H17F13
Molecular Weight
432.26  g/mol
InChI Key
WRYIIOKOQSICTB-UHFFFAOYSA-N
FDA UNII
7VYX4ELWQM

Perfluorohexyloctane
1 2D Structure

Perfluorohexyloctane

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorotetradecane
2.1.2 InChI
InChI=1S/C14H17F13/c1-2-3-4-5-6-7-8-9(15,16)10(17,18)11(19,20)12(21,22)13(23,24)14(25,26)27/h2-8H2,1H3
2.1.3 InChI Key
WRYIIOKOQSICTB-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCCCCCCC(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F
2.2 Other Identifiers
2.2.1 UNII
7VYX4ELWQM
2.3 Synonyms
2.3.1 MeSH Synonyms

1. F6h8 Cpd

2. Perfluorhexyl-octan

3. Perfluorohexyl-octan

4. Perfluorohexyloctane

2.3.2 Depositor-Supplied Synonyms

1. 133331-77-8

2. 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorotetradecane

3. Perfluorohexyloctane

4. 7vyx4elwqm

5. Perfluorohexyloctane [who-dd]

6. 1,1,1,2,2,3,3,4,4,5,5,6,6,-tridecafluorotetradecane

7. 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorotetradecane F 6h8

8. Tetradecane, 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluoro-

9. Starbld0000620

10. Unii-7vyx4elwqm

11. 1-(tridecafluorohexyl)octane

12. Schembl890448

13. Dtxsid20440585

14. Mfcd07784188

15. Akos015911101

16. Zinc100046937

17. Bs-20913

18. Cs-0205555

19. A806597

20. J-006351

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 432.26 g/mol
Molecular Formula C14H17F13
XLogP38.7
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count13
Rotatable Bond Count11
Exact Mass432.1122666 g/mol
Monoisotopic Mass432.1122666 g/mol
Topological Polar Surface Area0 Ų
Heavy Atom Count27
Formal Charge0
Complexity464
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDelivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.

Flag India
Digital Content Digital Content

Perfluorohexyloctane

About the Company : Mankind Pharma, came into existence in 1986. In 1991, the company was formed into a legal corporation. However, it actively started working as a fully integrated pharmaceutical com...

Mankind Pharma, came into existence in 1986. In 1991, the company was formed into a legal corporation. However, it actively started working as a fully integrated pharmaceutical company in 1995. Today, we have 11,000 employees and are heading towards a turnover of INR 50000 million. Our vast network includes 50 C&F agents and 7500+ stockists. We provide a wide range of products – Antibiotic, Antifungal, NSAIDs, Gastrointestinal, Anthelmintic, Cardiovascular, Dermal, Erectile Dysfunction, and several other categories – across the nation.
Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content

Perfluorohexyloctane

About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
Metrochem

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

Perfluorohexyloctane

About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...

Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK & are inspected by international regulatory authorities on a regular basis. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale
Dr Reddy Company Banner

04

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Perfluorohexyloctane

About the Company : Micro Labs Limited is a diversified healthcare company with cutting-edge R&D, advanced manufacturing facilities, and a strong distribution network. It ranks among India's top pharm...

Micro Labs Limited is a diversified healthcare company with cutting-edge R&D, advanced manufacturing facilities, and a strong distribution network. It ranks among India's top pharmaceutical companies, with a leading presence in cardiology, diabetology, anti-infectives, ophthalmology, and pain management. The company is known for its high-quality medicines, including the popular fever management brand, Dolo. Micro Labs continues to grow through innovation, research, and global expansion, delivering healthcare solutions that meet international standards.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

MIEBO (perfluorohexyloctane ophthalmic solution) is used for the treatment of the signs and symptoms of dry eye disease (DED). MIEBO is the first and only prescription eye drop approved for DED that directly targets tear evaporation.


Lead Product(s): Perfluorohexyloctane

Therapeutic Area: Ophthalmology Brand Name: Miebo

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 12, 2023

blank

01

ASPEN
Not Confirmed
ASPEN
Not Confirmed

Details : MIEBO (perfluorohexyloctane ophthalmic solution) is used for the treatment of the signs and symptoms of dry eye disease (DED). MIEBO is the first and only prescription eye drop approved for DED that directly targets tear evaporation.

Product Name : Miebo

Product Type : Small molecule

Upfront Cash : Not Applicable

September 12, 2023

blank

Details:

Under the agreement, Senju acquires Japan rights to develop, manufacture, and commercialize NOV03 (perfluorohexyloctane ophthalmic solution), the first and only prescription treatment for signs and symptoms of dry eye disease that directly targets tear evaporation.


Lead Product(s): Perfluorohexyloctane

Therapeutic Area: Ophthalmology Brand Name: NOV'03

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: SENJU PHARMACEUTICAL CO LTD

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement June 13, 2023

blank

02

Novaliq

Germany
arrow
ASPEN
Not Confirmed

Novaliq

Germany
arrow
ASPEN
Not Confirmed

Details : Under the agreement, Senju acquires Japan rights to develop, manufacture, and commercialize NOV03 (perfluorohexyloctane ophthalmic solution), the first and only prescription treatment for signs and symptoms of dry eye disease that directly targets tear e...

Product Name : NOV'03

Product Type : Small molecule

Upfront Cash : Undisclosed

June 13, 2023

blank

Details:

Miebo (perfluorohexyloctane) is the first drug approved by USFDA to treat dry eye disease associated with Meibomian gland dysfunction. It stabilizes the lipid layer for hours to protect the tear film and has the ability to penetrate the Meibomian glands.


Lead Product(s): Perfluorohexyloctane

Therapeutic Area: Ophthalmology Brand Name: Miebo

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Novaliq

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable May 18, 2023

blank

03

ASPEN
Not Confirmed
ASPEN
Not Confirmed

Details : Miebo (perfluorohexyloctane) is the first drug approved by USFDA to treat dry eye disease associated with Meibomian gland dysfunction. It stabilizes the lipid layer for hours to protect the tear film and has the ability to penetrate the Meibomian glands.

Product Name : Miebo

Product Type : Small molecule

Upfront Cash : Not Applicable

May 18, 2023

blank

Details:

NOV03 (Perfluorohexyloctane) is the first drug developed to treat dry eye disease associated with Meibomian gland dysfunction in a highly effective way. It stabilizes the lipid layer for hours to protect the tear film and has the ability to penetrate the Meibomian glands.


Lead Product(s): Perfluorohexyloctane

Therapeutic Area: Ophthalmology Brand Name: 37926

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Novaliq

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable January 04, 2023

blank

04

ASPEN
Not Confirmed
ASPEN
Not Confirmed

Details : NOV03 (Perfluorohexyloctane) is the first drug developed to treat dry eye disease associated with Meibomian gland dysfunction in a highly effective way. It stabilizes the lipid layer for hours to protect the tear film and has the ability to penetrate the...

Product Name : 37926

Product Type : Small molecule

Upfront Cash : Not Applicable

January 04, 2023

blank

Details:

NOV03 (perfluorohexyloctane) A potential first-in-class eye drop with a novel mechanism of action, NOV03 is an investigational therapy to treat the signs and symptoms of dry eye disease (DED) associated with Meibomian gland dysfunction (MGD).


Lead Product(s): Perfluorohexyloctane

Therapeutic Area: Ophthalmology Brand Name: 37926

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Novaliq

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 06, 2022

blank

05

ASPEN
Not Confirmed
ASPEN
Not Confirmed

Details : NOV03 (perfluorohexyloctane) A potential first-in-class eye drop with a novel mechanism of action, NOV03 is an investigational therapy to treat the signs and symptoms of dry eye disease (DED) associated with Meibomian gland dysfunction (MGD).

Product Name : 37926

Product Type : Small molecule

Upfront Cash : Not Applicable

September 06, 2022

blank

Details:

NOV03 (perfluorohexyloctane) Ophthalmic Soluton, is an investigational, proprietary, water-free, single-component preservative-free eye drop , an investigational treatment with a proposed indication of treating the signs and symptoms of dry eye disease.


Lead Product(s): Perfluorohexyloctane

Therapeutic Area: Ophthalmology Brand Name: 37926

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Novaliq

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 07, 2022

blank

06

ASPEN
Not Confirmed
ASPEN
Not Confirmed

Details : NOV03 (perfluorohexyloctane) Ophthalmic Soluton, is an investigational, proprietary, water-free, single-component preservative-free eye drop , an investigational treatment with a proposed indication of treating the signs and symptoms of dry eye disease.

Product Name : 37926

Product Type : Small molecule

Upfront Cash : Not Applicable

July 07, 2022

blank

Details:

NOV03 (perfluorohexyloctane) is being investigated as a first-in-class treatment with a novel mechanism of action to treat the signs and symptoms of dry eye disease (DED) associated with Meibomian gland dysfunction (MGD).


Lead Product(s): Perfluorohexyloctane

Therapeutic Area: Ophthalmology Brand Name: 37926

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable May 03, 2022

blank

07

ASPEN
Not Confirmed
ASPEN
Not Confirmed

Details : NOV03 (perfluorohexyloctane) is being investigated as a first-in-class treatment with a novel mechanism of action to treat the signs and symptoms of dry eye disease (DED) associated with Meibomian gland dysfunction (MGD).

Product Name : 37926

Product Type : Small molecule

Upfront Cash : Not Applicable

May 03, 2022

blank

Details:

Presentations include results from Phase 3 trials of investigational NOV03 (perfluorohexyloctane), as well as from several studies involving products from company's consumer health care, pharmaceutical and surgical portfolios, such as XIPERE for suprachoroidal use.


Lead Product(s): Perfluorohexyloctane

Therapeutic Area: Ophthalmology Brand Name: NOV03

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 28, 2022

blank

08

ASPEN
Not Confirmed
ASPEN
Not Confirmed

Details : Presentations include results from Phase 3 trials of investigational NOV03 (perfluorohexyloctane), as well as from several studies involving products from company's consumer health care, pharmaceutical and surgical portfolios, such as XIPERE for supracho...

Product Name : NOV03

Product Type : Small molecule

Upfront Cash : Not Applicable

April 28, 2022

blank

Details:

The data show that NOV03, (perfluorohexyloctane) met both primary endpoints of total Corneal Fluorescein Staining, a measure that assesses damage to the eye, and visual analogue scale dryness score at day 57.


Lead Product(s): Perfluorohexyloctane

Therapeutic Area: Ophthalmology Brand Name: NOV03

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Bausch & Lomb Incorporated

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 25, 2022

blank

09

Novaliq

Germany
arrow
ASPEN
Not Confirmed

Novaliq

Germany
arrow
ASPEN
Not Confirmed

Details : The data show that NOV03, (perfluorohexyloctane) met both primary endpoints of total Corneal Fluorescein Staining, a measure that assesses damage to the eye, and visual analogue scale dryness score at day 57.

Product Name : NOV03

Product Type : Small molecule

Upfront Cash : Not Applicable

April 25, 2022

blank

Details:

Company provided update on phase 3 trial of SHR8058 eye drops (perfluorohexyloctane) for the treatment of dry eye disease associated with Meibomian gland dysfunction and the trial met its prespecified primary sign endpoint improvement of total corneal fluorescein staining.


Lead Product(s): Perfluorohexyloctane

Therapeutic Area: Ophthalmology Brand Name: SHR8058

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable December 16, 2021

blank

10

Novaliq

Germany
arrow
ASPEN
Not Confirmed

Novaliq

Germany
arrow
ASPEN
Not Confirmed

Details : Company provided update on phase 3 trial of SHR8058 eye drops (perfluorohexyloctane) for the treatment of dry eye disease associated with Meibomian gland dysfunction and the trial met its prespecified primary sign endpoint improvement of total corneal fl...

Product Name : SHR8058

Product Type : Small molecule

Upfront Cash : Not Applicable

December 16, 2021

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 133331-77-8 / Perfluorohexyloctane API manufacturers, exporters & distributors?

Perfluorohexyloctane manufacturers, exporters & distributors 1

15

PharmaCompass offers a list of Perfluorohexyloctane API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Perfluorohexyloctane manufacturer or Perfluorohexyloctane supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Perfluorohexyloctane manufacturer or Perfluorohexyloctane supplier.

PharmaCompass also assists you with knowing the Perfluorohexyloctane API Price utilized in the formulation of products. Perfluorohexyloctane API Price is not always fixed or binding as the Perfluorohexyloctane Price is obtained through a variety of data sources. The Perfluorohexyloctane Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Perfluorohexyloctane

Synonyms

133331-77-8, 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorotetradecane, 7vyx4elwqm, Perfluorohexyloctane [who-dd], 1,1,1,2,2,3,3,4,4,5,5,6,6,-tridecafluorotetradecane, 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorotetradecane f 6h8

Cas Number

133331-77-8

Unique Ingredient Identifier (UNII)

7VYX4ELWQM

Perfluorohexyloctane Manufacturers

A Perfluorohexyloctane manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Perfluorohexyloctane, including repackagers and relabelers. The FDA regulates Perfluorohexyloctane manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Perfluorohexyloctane API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Perfluorohexyloctane manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Perfluorohexyloctane Suppliers

A Perfluorohexyloctane supplier is an individual or a company that provides Perfluorohexyloctane active pharmaceutical ingredient (API) or Perfluorohexyloctane finished formulations upon request. The Perfluorohexyloctane suppliers may include Perfluorohexyloctane API manufacturers, exporters, distributors and traders.

click here to find a list of Perfluorohexyloctane suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Perfluorohexyloctane USDMF

A Perfluorohexyloctane DMF (Drug Master File) is a document detailing the whole manufacturing process of Perfluorohexyloctane active pharmaceutical ingredient (API) in detail. Different forms of Perfluorohexyloctane DMFs exist exist since differing nations have different regulations, such as Perfluorohexyloctane USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Perfluorohexyloctane DMF submitted to regulatory agencies in the US is known as a USDMF. Perfluorohexyloctane USDMF includes data on Perfluorohexyloctane's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Perfluorohexyloctane USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Perfluorohexyloctane suppliers with USDMF on PharmaCompass.

Perfluorohexyloctane GMP

Perfluorohexyloctane Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Perfluorohexyloctane GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Perfluorohexyloctane GMP manufacturer or Perfluorohexyloctane GMP API supplier for your needs.

Perfluorohexyloctane CoA

A Perfluorohexyloctane CoA (Certificate of Analysis) is a formal document that attests to Perfluorohexyloctane's compliance with Perfluorohexyloctane specifications and serves as a tool for batch-level quality control.

Perfluorohexyloctane CoA mostly includes findings from lab analyses of a specific batch. For each Perfluorohexyloctane CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Perfluorohexyloctane may be tested according to a variety of international standards, such as European Pharmacopoeia (Perfluorohexyloctane EP), Perfluorohexyloctane JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Perfluorohexyloctane USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty